These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 35350195)
1. Humoral and cellular immune memory to four COVID-19 vaccines. Zhang Z; Mateus J; Coelho CH; Dan JM; Moderbacher CR; Gálvez RI; Cortes FH; Grifoni A; Tarke A; Chang J; Escarrega EA; Kim C; Goodwin B; Bloom NI; Frazier A; Weiskopf D; Sette A; Crotty S bioRxiv; 2022 Mar; ():. PubMed ID: 35350195 [TBL] [Abstract][Full Text] [Related]
2. Humoral and cellular immune memory to four COVID-19 vaccines. Zhang Z; Mateus J; Coelho CH; Dan JM; Moderbacher CR; Gálvez RI; Cortes FH; Grifoni A; Tarke A; Chang J; Escarrega EA; Kim C; Goodwin B; Bloom NI; Frazier A; Weiskopf D; Sette A; Crotty S Cell; 2022 Jul; 185(14):2434-2451.e17. PubMed ID: 35764089 [TBL] [Abstract][Full Text] [Related]
3. Serious adverse reaction associated with the COVID-19 vaccines of BNT162b2, Ad26.COV2.S, and mRNA-1273: Gaining insight through the VAERS. Yan MM; Zhao H; Li ZR; Chow JW; Zhang Q; Qi YP; Wu SS; Zhong MK; Qiu XY Front Pharmacol; 2022; 13():921760. PubMed ID: 36419624 [No Abstract] [Full Text] [Related]
4. Comparing the human milk antibody response after vaccination with four COVID-19 vaccines: A prospective, longitudinal cohort study in the Netherlands. Juncker HG; Mulleners SJ; Ruhé EJM; Coenen ERM; Bakker S; van Doesburg M; Harinck JE; Rood RD; Bouhuijs JH; Oomen M; de Groot PCJM; Pajkrt PD; Korosi A; van Goudoever PJB; van Gils MJ; van Keulen BJ EClinicalMedicine; 2022 May; 47():101393. PubMed ID: 35465077 [TBL] [Abstract][Full Text] [Related]
5. Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study. Costa Clemens SA; Weckx L; Clemens R; Almeida Mendes AV; Ramos Souza A; Silveira MBV; da Guarda SNF; de Nobrega MM; de Moraes Pinto MI; Gonzalez IGS; Salvador N; Franco MM; de Avila Mendonça RN; Queiroz Oliveira IS; de Freitas Souza BS; Fraga M; Aley P; Bibi S; Cantrell L; Dejnirattisai W; Liu X; Mongkolsapaya J; Supasa P; Screaton GR; Lambe T; Voysey M; Pollard AJ; Lancet; 2022 Feb; 399(10324):521-529. PubMed ID: 35074136 [TBL] [Abstract][Full Text] [Related]
6. Vaccine-Acquired SARS-CoV-2 Immunity versus Infection-Acquired Immunity: A Comparison of Three COVID-19 Vaccines. Samanovic MI; Oom AL; Cornelius AR; Gray-Gaillard SL; Karmacharya T; Tuen M; Wilson JP; Tasissa MF; Goins S; Herati RS; Mulligan MJ Vaccines (Basel); 2022 Dec; 10(12):. PubMed ID: 36560562 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of humoral and cellular response to four vaccines against COVID-19 in different age groups: A longitudinal study. Fedele G; Trentini F; Schiavoni I; Abrignani S; Antonelli G; Baldo V; Baldovin T; Bandera A; Bonura F; Clerici P; De Paschale M; Fortunato F; Gori A; Grifantini R; Icardi G; Lazzarotto T; Lodi V; Mastroianni CM; Orsi A; Prato R; Restivo V; Carsetti R; Piano Mortari E; Leone P; Olivetta E; Fiore S; Di Martino A; Brusaferro S; Merler S; Palamara AT; Stefanelli P Front Immunol; 2022; 13():1021396. PubMed ID: 36389704 [TBL] [Abstract][Full Text] [Related]
8. NVX-CoV2373 vaccination induces functional SARS-CoV-2-specific CD4+ and CD8+ T cell responses. Rydyznski Moderbacher C; Kim C; Mateus J; Plested J; Zhu M; Cloney-Clark S; Weiskopf D; Sette A; Fries L; Glenn G; Crotty S J Clin Invest; 2022 Oct; 132(19):. PubMed ID: 35943810 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 Neutralizing Antibodies: A Network Meta-Analysis across Vaccines. Rogliani P; Chetta A; Cazzola M; Calzetta L Vaccines (Basel); 2021 Mar; 9(3):. PubMed ID: 33807818 [No Abstract] [Full Text] [Related]
10. Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection. Moyo-Gwete T; Richardson SI; Keeton R; Hermanus T; Spencer H; Manamela NP; Ayres F; Makhado Z; Motlou T; Tincho MB; Benede N; Ngomti A; Baguma R; Chauke MV; Mennen M; Adriaanse M; Skelem S; Goga A; Garrett N; Bekker LG; Gray G; Ntusi NAB; Riou C; Burgers WA; Moore PL medRxiv; 2023 Mar; ():. PubMed ID: 36993404 [TBL] [Abstract][Full Text] [Related]
11. Protein vaccine NVX-CoV2373 elicits functional T cell immunity. Zhou P J Clin Invest; 2022 Oct; 132(19):. PubMed ID: 36189797 [TBL] [Abstract][Full Text] [Related]
12. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting. Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J Front Immunol; 2021; 12():802858. PubMed ID: 35003131 [TBL] [Abstract][Full Text] [Related]
14. Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections. Desmecht S; Tashkeev A; El Moussaoui M; Marechal N; Perée H; Tokunaga Y; Fombellida-Lopez C; Polese B; Legrand C; Wéry M; Mni M; Fouillien N; Toussaint F; Gillet L; Bureau F; Lutteri L; Hayette MP; Moutschen M; Meuris C; Vermeersch P; Desmecht D; Rahmouni S; Darcis G Front Immunol; 2022; 13():863554. PubMed ID: 35711445 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the Immune Responses to COVID-19 Vaccines in Bangladeshi Population. Sarker P; Akhtar E; Kuddusi RU; Alam MM; Haq MA; Hosen MB; Chanda BC; Haque F; Alam M; Razzaque A; Rahman M; Ahmed F; Kibria MG; Islam MZ; Ahmed S; Raqib R Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146576 [TBL] [Abstract][Full Text] [Related]